Uy IPHASE DS8201a

IPHASE DS8201a

Qisqacha tavsif:

DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.

HOZIR BOG'LANING Savatga qo'shing

Mahsulot detali

Mahsulot teglari

Mahsulot tavsifi DS-8201a, shuningdek, trastuzumab deruxtekan (T-DXd) sifatida ham tanilgan, HER2-musbat saraton kasalliklarini davolash uchun mo'ljallangan antikor-dori konjugati (ADC). U HER2-maqsadli monoklonal antikorni (trastuzumabga o'xshash) sitotoksik yuk sifatida kuchli topoizomeraz I inhibitori (deruxtekan) bilan birlashtiradi. Preparat kimyoviy terapiyani to'g'ridan-to'g'ri HER2 ni ifodalovchi saraton hujayralariga etkazib beradi, bu esa samaradorlikni oshiradi va normal hujayralarga zarar yetkazishni cheklaydi.

Turkum:
Katepsin
Element №:
015200.01
Birlik o'lchami:
50uL, 2mg/ml
To'qima:
Yoʻq
Turlari:
Yoʻq
Saqlash shartlari va tashish:
-70°C da saqlang. Quruq muz yetkazib beriladi.